No abstract

No abstract

No abstract

Polymer blends along with 1-(4-methylphenyl)-3-(4-N,N, dimethyl amino phenyl)-2-propen-1-one (MPDMAPP) NLO-chromophore-doped composite films were prepared by solvent casting method using DMF. The optical properties were studied using UV-visible, refractive index, steady state fluorescence, and fluorescence microscopic imaging techniques. The UV-vis absorption spectra showed three absorption bands and were assigned to localized n ? p*, n ? p* inter band, and p ? p* transition of charge transfer groups. The observed changes in the absorption peak, edges, and intensity with dopant concentration are understood based on charge transfer complex (CTC) formation. The refractive indices of the composite films varied from 1.4937-1.5398 for red and 1.5165-1.5516 for green light respectively. The steady state fluorescence data showed both emission peak wavelengths and intensity changes with MPDMAPP doping level in blend. The fluorescence anisotropy (r) variations in the composite films indicate the suppressed molecular motion of MPDMAPP in the solid composite film. The fluorescence microscopic image of these composite films showed that the films are photochromatic in nature. These modified properties are thought to be due to the charge transfer upon excitation from the donor to the acceptor connected through benzene ring and CTC formation. POLYM. ENG. SCI.,

No abstract

A new class of compounds formed by the linkage of −C(O)–NH– with pyridine and thiazole moieties was designed, synthesized, and characterized by various spectral approaches. The newly characterized compounds were evaluated for their antimicrobial as well as anti-inflammatory properties. The in vitro anti-inflammatory activity of these compounds was evaluated by denaturation of the bovine serum albumin method and showed inhibition in the range of IC 50 values—46.29–100.60 μg/mL. Among all the tested compounds, compound 5l has the highest IC 50 value and compound 5g has the least IC 50 value. On the other hand, antimicrobial results revealed that compound 5j showed the lowest MIC values and compound 5a has the highest MIC values. Furthermore, molecular docking of the active compounds demonstrated a better docking score and interacted well with the target protein. Physicochemical parameters of the titled compounds were found suitable in the reference range only. The in silico molecular docking study revealed their COX-inhibitory action. Compound 5j emerged as a significant bioactive molecule among the synthesized analogues.

No abstract

The current study evaluates antidiabetic, anticoagulant, and antiplatelet activity of novel benzimidazole-containing quinolinyl oxadiazoles. These derivatives are synthesized and characterized using spectroscopy (FT-IR, 1H NMR, and mass spectroscopy) and single-crystal X-ray diffraction methods. The inhibitory effects of these compounds were evaluated by the α-glucosidase inhibitory assay and shows the activity in the range of IC50 = 0.66 ± 0.05 to 3.79 ± 0.46 μg/mL. In addition, molecular docking studies revealed that benzimidazole-containing quinolinyl oxadiazoles can correctly dock into the target receptor protein of the human intestinal α-glucosidase, while their bioavailability/drug-likeness was predicted to be acceptable but requires further optimization. On the other hand, compound 8a and 8d showed anticoagulant activity as they enhanced the clotting time from control 180–410 and 180–390 s, respectively, in platelet rich plasma and 230–460 and 230–545 s in platelet poor plasma. Furthermore, only 8a showed antiplatelet activity by inhibiting epinephrine-induced platelet aggregation, and the observed aggregation inhibition was found to be 93.4%. Compounds 8a–f show nontoxic properties because of the non-hydrolyzing properties in the RBC cells. In addition, 8a and 8d show anti-edema and anti-hemorrhagic properties in the experimental mice. These findings reveal that benzimidazole-containing quinolinyl oxadiazoles act as α-glucosidase inhibitors to develop novel therapeutics for treating type-II diabetes mellitus and can act as lead molecules in drug discovery as potential antidiabetic and antithrombotic agents.